Search results
Europe Awaits Decision on New Duchenne Drug
Medscape· 4 days agoThe US Food and Drug Administration (FDA) has recently approved Duvyzat (givinostat), the first nonsteroidal therapy for children aged 6 years and older who have all hereditary variants of Duchenne ...
Camber’s CEO Highlights Growth & Transformation Following Merger
Digital Journal· 5 days agoHOUSTON, TX / ACCESSWIRE / June 20, 2024 / Camber Energy, Inc. (NYSE American:CEI) ("Camber" or the "Company"), a growth-oriented diversified energy company, today shares an open letter to shareholders ...